DOI: 10.1016/s0140-6736(00)05113-8. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial

10.1016/s0140-6736(00)05113-8

Crossref journal-article

Elsevier BV

The Lancet (78)

Bibliography

Robinson, D. S., Campbell, D., & Barnes, P. J. (2001). Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. The Lancet, 357(9273), 2007â2011.

Authors 3

Douglas S Robinson (first)
Debbie Campbell (additional)
Peter J Barnes (additional)

References 21 Referenced 126

10.1056/NEJM199901213400306 / N Engl J Med / Treatment of asthma with drugs modifying the leukotriene pathway by Drazen (1999)
10.1136/bmj.316.7140.1257 / BMJ / Leukotriene modifiers in the treatment of asthma by Sampson (1998)
10.1164/ajrccm/146.2.358 / Am Rev Respir Dis / Bronchodilation with a potent and selective leukotriene D4 receptor antagonist (MK-571) in patients with asthma by Gaddy (1992)
10.1136/thx.52.1.45 / Thorax / Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids by Reiss (1997)
10.1034/j.1399-3003.1999.14a04.x / Eur Respir J / Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial by Pizzichini (1999)
10.1056/NEJM199807163390302 / N Engl J Med / Montelukast, a leukotriene receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction by Leff (1998)
10.1016/S0091-6749(98)70054-5 / J Allergy Clin Immunol / A placebo-controlled dose-ranging study of montelukast, a cysteinyl leukotriene receptor antagonist by Altman (1998)
10.1136/bmj.319.7202.87 / BMJ / Randomized, placebo controlled trial of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients by Lofdahl (1999)
10.1164/ajrccm.160.6.9803042 / Am J Respir Crit Care Med / Montelukast added to inhaled beclomethasone in treatment of asthma by Laviolette (1999)
10.1183/09031936.98.12051209 / Eur Respir J / Difficult asthma by Barnes (1998)
{'key': '10.1016/S0140-6736(00)05113-8_bib11', 'first-page': '1007', 'article-title': 'Standardization of spirometry', 'volume': '152', 'author': 'American Thoracic Society', 'year': '1995', 'journal-title': 'Am J Respir Crit Care Med'} / Am J Respir Crit Care Med / Standardization of spirometry by American Thoracic Society (1995)
10.1016/S0091-6749(98)70165-4 / J Allergy Clin Immunol / Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma by Chan (1998)
10.1016/S0091-6749(98)70331-8 / J Allergy Clin Immunol / Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction by Nathan (1998)
10.1016/S0091-6749(99)70498-7 / J Allergy Clin Immunol / An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses by Tashkin (1999)
Virchow JC, Hassal SM, Summerton L, aHrris A. Improved asthma control over 6 weeks with Accolate (zafirlukast) in patients on high dose inhaled corticosteroids. J Invest Med 45: 286A (abstract)
10.1164/ajrccm.149.4.8143061 / Am J Respir Crit Care Med / Effect of oral prednisone on airway inflammatory mediators in atopic asthma by Dworski (1994)
10.1164/ajrccm/147.6_Pt_1.1472 / Am Rev Respir Dis / Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion by O'Shaughnessy (1993)
10.1164/ajrccm/148.6_Pt_1.1447 / Am Rev Respir Dis / The pivotal role of 5-lipoxygenase products in the reaction of aspirin sensitive asthmatics to aspirin by Israel (1993)
10.1164/ajrccm.157.4.9707089 / Am J Respir Crit Care Med / Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics by Dahlen (1998)
10.1038/9680 / Nat Genet / Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment by Drazen (1999)
10.1111/j.1398-9995.1999.tb05027.x / Allergy / Inhaled corticosteroids versus anti-leukotrienes: a literature review on the clinical effects by Ind (1999)

Dates

Type	When
Created	23 years, 1 month ago (July 25, 2002, 8:29 a.m.)
Deposited	6 years, 4 months ago (April 25, 2019, 5:22 p.m.)
Indexed	2 months, 1 week ago (June 17, 2025, 11:11 a.m.)
Issued	24 years, 2 months ago (June 1, 2001)
Published	24 years, 2 months ago (June 1, 2001)
Published Print	24 years, 2 months ago (June 1, 2001)

Funders 0

None

BibTeX

@article{Robinson_2001, title={Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial}, volume={357}, ISSN={0140-6736}, url={http://dx.doi.org/10.1016/s0140-6736(00)05113-8}, DOI={10.1016/s0140-6736(00)05113-8}, number={9273}, journal={The Lancet}, publisher={Elsevier BV}, author={Robinson, Douglas S and Campbell, Debbie and Barnes, Peter J}, year={2001}, month=jun, pages={2007–2011} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        6,
        17
      ]
    ],
    "date-time": "2025-06-17T15:11:59Z",
    "timestamp": 1750173119256
  },
  "reference-count": 21,
  "publisher": "Elsevier BV",
  "issue": "9273",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2001,
            6,
            1
          ]
        ],
        "date-time": "2001-06-01T00:00:00Z",
        "timestamp": 991353600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2001,
        6
      ]
    ]
  },
  "DOI": "10.1016/s0140-6736(00)05113-8",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        25
      ]
    ],
    "date-time": "2002-07-25T12:29:37Z",
    "timestamp": 1027600177000
  },
  "page": "2007-2011",
  "source": "Crossref",
  "is-referenced-by-count": 126,
  "title": "Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial",
  "prefix": "10.1016",
  "volume": "357",
  "author": [
    {
      "given": "Douglas S",
      "family": "Robinson",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Debbie",
      "family": "Campbell",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Peter J",
      "family": "Barnes",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "DOI": "10.1056/NEJM199901213400306",
      "article-title": "Treatment of asthma with drugs modifying the leukotriene pathway",
      "volume": "340",
      "author": "Drazen",
      "year": "1999",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "1257",
      "DOI": "10.1136/bmj.316.7140.1257",
      "article-title": "Leukotriene modifiers in the treatment of asthma",
      "volume": "316",
      "author": "Sampson",
      "year": "1998",
      "journal-title": "BMJ"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "358",
      "DOI": "10.1164/ajrccm/146.2.358",
      "article-title": "Bronchodilation with a potent and selective leukotriene D4 receptor antagonist (MK-571) in patients with asthma",
      "volume": "146",
      "author": "Gaddy",
      "year": "1992",
      "journal-title": "Am Rev Respir Dis"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "45",
      "DOI": "10.1136/thx.52.1.45",
      "article-title": "Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids",
      "volume": "52",
      "author": "Reiss",
      "year": "1997",
      "journal-title": "Thorax"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "12",
      "DOI": "10.1034/j.1399-3003.1999.14a04.x",
      "article-title": "Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial",
      "volume": "14",
      "author": "Pizzichini",
      "year": "1999",
      "journal-title": "Eur Respir J"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "DOI": "10.1056/NEJM199807163390302",
      "article-title": "Montelukast, a leukotriene receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction",
      "volume": "339",
      "author": "Leff",
      "year": "1998",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "50",
      "DOI": "10.1016/S0091-6749(98)70054-5",
      "article-title": "A placebo-controlled dose-ranging study of montelukast, a cysteinyl leukotriene receptor antagonist",
      "volume": "102",
      "author": "Altman",
      "year": "1998",
      "journal-title": "J Allergy Clin Immunol"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "87",
      "DOI": "10.1136/bmj.319.7202.87",
      "article-title": "Randomized, placebo controlled trial of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients",
      "volume": "319",
      "author": "Lofdahl",
      "year": "1999",
      "journal-title": "BMJ"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "1862",
      "DOI": "10.1164/ajrccm.160.6.9803042",
      "article-title": "Montelukast added to inhaled beclomethasone in treatment of asthma",
      "volume": "160",
      "author": "Laviolette",
      "year": "1999",
      "journal-title": "Am J Respir Crit Care Med"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "1209",
      "DOI": "10.1183/09031936.98.12051209",
      "article-title": "Difficult asthma",
      "volume": "12",
      "author": "Barnes",
      "year": "1998",
      "journal-title": "Eur Respir J"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib11",
      "first-page": "1007",
      "article-title": "Standardization of spirometry",
      "volume": "152",
      "author": "American Thoracic Society",
      "year": "1995",
      "journal-title": "Am J Respir Crit Care Med"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "594",
      "DOI": "10.1016/S0091-6749(98)70165-4",
      "article-title": "Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma",
      "volume": "101",
      "author": "Chan",
      "year": "1998",
      "journal-title": "J Allergy Clin Immunol"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "935",
      "DOI": "10.1016/S0091-6749(98)70331-8",
      "article-title": "Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction",
      "volume": "102",
      "author": "Nathan",
      "year": "1998",
      "journal-title": "J Allergy Clin Immunol"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "246",
      "DOI": "10.1016/S0091-6749(99)70498-7",
      "article-title": "An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses",
      "volume": "103",
      "author": "Tashkin",
      "year": "1999",
      "journal-title": "J Allergy Clin Immunol"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib15",
      "unstructured": "Virchow JC, Hassal SM, Summerton L, aHrris A. Improved asthma control over 6 weeks with Accolate (zafirlukast) in patients on high dose inhaled corticosteroids. J Invest Med 45: 286A (abstract)"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "953",
      "DOI": "10.1164/ajrccm.149.4.8143061",
      "article-title": "Effect of oral prednisone on airway inflammatory mediators in atopic asthma",
      "volume": "149",
      "author": "Dworski",
      "year": "1994",
      "journal-title": "Am J Respir Crit Care Med"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "1472",
      "DOI": "10.1164/ajrccm/147.6_Pt_1.1472",
      "article-title": "Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion",
      "volume": "147",
      "author": "O'Shaughnessy",
      "year": "1993",
      "journal-title": "Am Rev Respir Dis"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "1447",
      "DOI": "10.1164/ajrccm/148.6_Pt_1.1447",
      "article-title": "The pivotal role of 5-lipoxygenase products in the reaction of aspirin sensitive asthmatics to aspirin",
      "volume": "148",
      "author": "Israel",
      "year": "1993",
      "journal-title": "Am Rev Respir Dis"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "1187",
      "DOI": "10.1164/ajrccm.157.4.9707089",
      "article-title": "Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics",
      "volume": "157",
      "author": "Dahlen",
      "year": "1998",
      "journal-title": "Am J Respir Crit Care Med"
    },
    {
      "key": "10.1016/S0140-6736(00)05113-8_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "168",
      "DOI": "10.1038/9680",
      "article-title": "Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment",
      "volume": "22",
      "author": "Drazen",
      "year": "1999",
      "journal-title": "Nat Genet"
    },
    {
      "issue": "suppl 50",
      "key": "10.1016/S0140-6736(00)05113-8_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "DOI": "10.1111/j.1398-9995.1999.tb05027.x",
      "article-title": "Inhaled corticosteroids versus anti-leukotrienes: a literature review on the clinical effects",
      "volume": "54",
      "author": "Ind",
      "year": "1999",
      "journal-title": "Allergy"
    }
  ],
  "container-title": "The Lancet",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0140673600051138?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0140673600051138?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        4,
        25
      ]
    ],
    "date-time": "2019-04-25T21:22:09Z",
    "timestamp": 1556227329000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0140673600051138"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2001,
        6
      ]
    ]
  },
  "references-count": 21,
  "journal-issue": {
    "issue": "9273",
    "published-print": {
      "date-parts": [
        [
          2001,
          6
        ]
      ]
    }
  },
  "alternative-id": [
    "S0140673600051138"
  ],
  "URL": "http://dx.doi.org/10.1016/S0140-6736(00)05113-8",
  "relation": {},
  "ISSN": [
    "0140-6736"
  ],
  "subject": [],
  "container-title-short": "The Lancet",
  "published": {
    "date-parts": [
      [
        2001,
        6
      ]
    ]
  }
}